A clinical MALDI-ToF Mass spectrometry assay for SARS-CoV-2: Rational design and multi-disciplinary team work (2020)

First Author: Iles R

Attributed to: One Health and accelerating Vaccines for Ebola and Lassa (OVEL) funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2020.08.22.20176669

Publication URI: http://dx.doi.org/10.1101/2020.08.22.20176669

Type: Preprint